Valuation: BioGaia AB

Market Cap 11.71B 1.18B 1.03B 978M 887M 1.67B 113B 1.68B 4.52B 57.62B 4.42B 4.32B 185B P/E 2026 *
30.5x
P/E 2027 * 24.4x
Enterprise Value 11.05B 1.11B 976M 923M 837M 1.57B 107B 1.58B 4.27B 54.35B 4.17B 4.08B 175B EV / Sales 2026 *
6.64x
EV / Sales 2027 * 5.87x
Free-Float
80.82%
Yield 2026 *
3.54%
Yield 2027 * 3.78%
1 day-1.47%
1 week+4.11%
Current month-0.52%
1 month-1.04%
3 months-3.31%
6 months-2.73%
Current year+7.44%
1 week 107.8
Extreme 107.8
118.3
1 month 105.4
Extreme 105.4
118.3
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 93.2
Extreme 93.2
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.7
Extreme 48.7
139.7
Manager TitleAgeSince
Chief Executive Officer 60 29/09/2023
Director of Finance/CFO 59 04/11/2019
Chief Operating Officer 49 31/12/2020
Director TitleAgeSince
Chairman 77 31/12/2002
Chairman 76 24/04/2018
Director/Board Member 46 31/12/2014
Date Insider Type Main position Quantity % Market Cap. Importance
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%+4.11%+6.94%+14.85% 1.18B
-0.15%+14.13%+679.19%+96.84% 79.4B
-4.54%-5.91%+33.93%-10.01% 78.69B
+2.80%+3.60%-6.34%-27.82% 59.52B
-0.89%+2.11%+7.92%+170.43% 46.58B
+2.49%+0.14%-8.95%+33.71% 46.53B
+0.50%+4.12%+64.67%-11.53% 33.63B
+0.68%+0.17%+48.84%+113.04% 25.11B
-3.56%-0.47%+3.11%+135.37% 22.13B
+0.73%-0.95%+57.27%+97.04% 15.31B
Average -0.38%+4.40%+88.66%+61.19% 40.81B
Weighted average by Cap. -0.45%+6.71%+148.33%+53.18%

Financials

2026 *2027 *
Net sales 1.66B 167M 147M 139M 126M 237M 16.05B 238M 643M 8.19B 628M 614M 26.32B 1.89B 189M 167M 158M 143M 268M 18.18B 270M 728M 9.28B 711M 696M 29.81B
Net income 385M 38.66M 34M 32.15M 29.17M 54.77M 3.71B 55.09M 149M 1.89B 145M 142M 6.09B 480M 48.2M 42.39M 40.09M 36.36M 68.29M 4.63B 68.68M 185M 2.36B 181M 177M 7.59B
Net Debt -666M -66.83M -58.78M -55.58M -50.41M -94.68M -6.42B -95.23M -257M -3.27B -251M -245M -10.52B -648M -65.02M -57.19M -54.08M -49.05M -92.12M -6.24B -92.65M -250M -3.19B -244M -239M -10.24B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
28/09/26 SEK 114.10 -1.47% 282,828
25/09/26 SEK 115.80 +1.58% 153,556
24/09/26 SEK 114.00 +3.45% 346,697
23/09/26 SEK 110.20 +1.01% 201,103
22/09/26 SEK 109.10 -0.46% 100,993
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
115.80SEK
Average target price
155.50SEK
Spread / Average Target
+34.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock